- priority setting/ethics
- methods and metrics
- costing methods
- health outcomes
- test performance
- value of information
- models and tools
- mathematical models
- state-transition
- dynamic transmission
- microsimulation
- calibration/validation
- dynamic simulation
- operations research
- climate/environment
- education/labor
- food/agriculture
- health/medicine
- north america
- oceania
Resources Repository
-
ArticlePublication 2007Modeling HPV and Cervical Cancer in the U.S. for Analyses of Screening and Vaccination
This paper discusses a model of human papillomavirus (HPV) and cervical cancer that incorporates uncertainty …
This paper discusses a model of human papillomavirus (HPV) and cervical cancer that incorporates uncertainty about the natural history of disease that was used to provide quantitative insight into U.S. policy choices for cervical cancer prevention. The authors developed a stochastic microsimulation of cervical cancer that distinguishes different HPV types by their incidence, clearance, persistence, and progression. For each set of sampled input parameters, likelihood-based goodness-of-fit (GOF) scores were computed based on comparisons between model-predicted…
Microsimulation | Calibration/Validation | Health/Medicine | North America | Infectious Diseases | Chronic Disease/Risk | Clinical Care | Science/Technology -
ArticlePublication 2023Catalogues of EQ-5D-3L Health-Related Quality of Life Scores for 199 Chronic Conditions and Health Risks for Use in the UK & the U.S.
This study aimed to create UK and US EQ-5D-3L-based health-related quality of life (HRQoL) utility …
This study aimed to create UK and US EQ-5D-3L-based health-related quality of life (HRQoL) utility population catalogues for 199 chronic conditions using ICD-10 codes and health risks. It also sought to develop regression models to predict these utilities in other populations. Methods involved applying UK and US EQ-5D-3L value sets to responses from a Danish dataset, which combined national health survey data with national registers containing patient information on diagnoses, healthcare activities, and socio-demographics. Adjusted…
Health Outcomes | Health/Medicine | North America | Preferences/Values | Europe -
ArticlePublication 2023Cost-Effectiveness and Long-Term Savings of the Bright Bodies Intervention for Childhood Obesity
This study evaluates the cost-effectiveness of Bright Bodies, a family-based pediatric weight management intervention, using …
This study evaluates the cost-effectiveness of Bright Bodies, a family-based pediatric weight management intervention, using a microsimulation model projecting 10-year BMI trajectories of children with obesity. Data from a randomized controlled trial and follow-up study inform the model, which estimates the intervention's effect on BMI reduction and incremental costs compared to clinical control. Results indicate that Bright Bodies reduces BMI by 1.67 kg/m2 per year over 10 years, with an incremental cost of $360 per…
Microsimulation | Health/Medicine | North America | Cost-Effectiveness Analysis | Child/Nutrition -
ArticlePublication 2023New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, Cost-Effectiveness
This study presents a microsimulation model designed to estimate the health effects, costs, and cost-effectiveness …
This study presents a microsimulation model designed to estimate the health effects, costs, and cost-effectiveness of interventions for type 2 diabetes in the United States. Unlike existing models that rely on UK data, this model incorporates newly derived risk equations based on US studies, enhancing its applicability to the US context. The model features a highly modular architecture allowing for easy addition of new modules and interventions, facilitating policy decision-making. Internal validation showed good performance,…
Microsimulation | Health/Medicine | North America | Cost-Effectiveness Analysis | Chronic Disease/Risk -
ArticlePublication 2023Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, Geography for Equity-Informative CEA
This study addresses disparities in health outcomes among racial and ethnic groups in the United …
This study addresses disparities in health outcomes among racial and ethnic groups in the United States using Bayesian models to handle suppressed mortality data. By linking multiple US data sets, it demonstrates significant variations in life expectancy, disability-free life expectancy, and quality-adjusted life expectancy based on race, ethnicity, and geographic location. Results show that disparities persist and widen with age, especially between the best-off and worst-off subgroups in socially vulnerable counties. Life expectancy, disability-free life…
Health Outcomes | Health/Medicine | North America | Cost-Effectiveness Analysis | Social Determinants -
ArticlePublication 2023Performance of Rapid Antigen Tests to Detect Symptomatic and Asymptomatic SARS-CoV-2 Infection
The objective of this study was to evaluate the performance of rapid antigen tests (Ag-RDTs) …
The objective of this study was to evaluate the performance of rapid antigen tests (Ag-RDTs) for detection of SARS-CoV-2 among symptomatic and asymptomatic participants. The general findings were that the performance of Ag-RDTs was optimized when asymptomatic participants tested 3 times at 48-hour intervals and when symptomatic participants tested 2 times separated by 48 hours. Participants completed Ag-RDTs and reverse transcriptase polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 every 48 hours for 15 days. They…
Test Performance | Health/Medicine | North America | Infectious Diseases | Clinical Care | Science/Technology -
ArticlePublication 2020Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure
This study aimed to determine the false-negative rate of RT-PCR tests for SARS-CoV-2 infection based …
This study aimed to determine the false-negative rate of RT-PCR tests for SARS-CoV-2 infection based on the timeline of exposure and symptom onset. Drawing from data in seven studies involving 1,330 upper respiratory tract samples, a Bayesian model was used to estimate these rates. Findings showed that in the initial four days prior to typical symptom onset, the false-negative rate decreased from 100% on day 1 to 67% on day 4. By the day of…
Test Performance | Health/Medicine | North America | Infectious Diseases | Clinical Care | Science/Technology -
ReviewPublication 2021Considerations for Diagnostic COVID-19 Tests
During the initial stages of the COVID-19 pandemic, there was a rush by numerous diagnostic …
During the initial stages of the COVID-19 pandemic, there was a rush by numerous diagnostic test manufacturers to create, validate, and implement testing methods. This review discusses the pivotal role of diagnostic tests during the pandemic's first global wave, highlighting the challenges in technology and implementation experienced early on. The study also offers insights for enhancing the use of diagnostics, especially syndromic ones, should there be future spikes or regional outbreaks of COVID-19. The overarching…
Test Performance | Health/Medicine | North America | Infectious Diseases | Clinical Care | Science/Technology -
ReviewPublication 2022Rapid, Point-of-Care Antigen Tests for Diagnosis of SARS-CoV-2 Infection
This study reviewed the diagnostic accuracy of rapid, point-of-care antigen tests for detecting SARS-CoV-2 infection, …
This study reviewed the diagnostic accuracy of rapid, point-of-care antigen tests for detecting SARS-CoV-2 infection, differentiating results between symptomatic and asymptomatic individuals. Using data from 155 study cohorts, the study found that the sensitivity of antigen tests was generally higher for symptomatic individuals, especially during the first week after symptom onset, due to higher viral loads. For example, average sensitivity was higher in symptomatic (73.0%) compared to asymptomatic participants (54.7). Average sensitivity was higher in…
Test Performance | Health/Medicine | North America | Infectious Diseases | Clinical Care | Science/Technology